296 related articles for article (PubMed ID: 3762808)
1. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
2. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
3. [The tumor markers TPA and CEA in the after care of breast cancer].
Beaufort F; Fueger GF; Steiner H
Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
[TBL] [Abstract][Full Text] [Related]
4. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
5. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
6. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
7. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
8. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
[TBL] [Abstract][Full Text] [Related]
9. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
Lüthgens M; Schlegel G
Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of tumor markers in breast cancer patients].
Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
13. [CEA and TPA in cancer of the breast. Findings and criteria of use].
Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V
Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
[TBL] [Abstract][Full Text] [Related]
16. [Tissue polypeptide antigen in breast cancer].
Nomizu T; Watanabe I; Endo S
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
[No Abstract] [Full Text] [Related]
17. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P
Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
[TBL] [Abstract][Full Text] [Related]
18. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of tissue polypeptide antigen in breast cancer patients.
Mross K; Bandlow G
Anticancer Res; 1986; 6(2):223-5. PubMed ID: 3707059
[TBL] [Abstract][Full Text] [Related]
20. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
